AAPL   322.31 (+1.37%)
MSFT   182.59 (-0.36%)
FB   229.71 (+2.05%)
GOOGL   1,431.97 (-0.11%)
AMZN   2,467.55 (+1.03%)
NVDA   351.12 (-1.10%)
CGC   16.62 (-4.32%)
BABA   206.47 (-0.44%)
MU   46.51 (-2.92%)
GE   6.69 (+1.67%)
TSLA   887.88 (+6.33%)
T   31.00 (+0.45%)
F   5.83 (+2.10%)
GILD   75.66 (-2.79%)
DIS   119.14 (+1.57%)
NFLX   424.62 (+1.17%)
BA   151.28 (+3.72%)
AAPL   322.31 (+1.37%)
MSFT   182.59 (-0.36%)
FB   229.71 (+2.05%)
GOOGL   1,431.97 (-0.11%)
AMZN   2,467.55 (+1.03%)
NVDA   351.12 (-1.10%)
CGC   16.62 (-4.32%)
BABA   206.47 (-0.44%)
MU   46.51 (-2.92%)
GE   6.69 (+1.67%)
TSLA   887.88 (+6.33%)
T   31.00 (+0.45%)
F   5.83 (+2.10%)
GILD   75.66 (-2.79%)
DIS   119.14 (+1.57%)
NFLX   424.62 (+1.17%)
BA   151.28 (+3.72%)
AAPL   322.31 (+1.37%)
MSFT   182.59 (-0.36%)
FB   229.71 (+2.05%)
GOOGL   1,431.97 (-0.11%)
AMZN   2,467.55 (+1.03%)
NVDA   351.12 (-1.10%)
CGC   16.62 (-4.32%)
BABA   206.47 (-0.44%)
MU   46.51 (-2.92%)
GE   6.69 (+1.67%)
TSLA   887.88 (+6.33%)
T   31.00 (+0.45%)
F   5.83 (+2.10%)
GILD   75.66 (-2.79%)
DIS   119.14 (+1.57%)
NFLX   424.62 (+1.17%)
BA   151.28 (+3.72%)
AAPL   322.31 (+1.37%)
MSFT   182.59 (-0.36%)
FB   229.71 (+2.05%)
GOOGL   1,431.97 (-0.11%)
AMZN   2,467.55 (+1.03%)
NVDA   351.12 (-1.10%)
CGC   16.62 (-4.32%)
BABA   206.47 (-0.44%)
MU   46.51 (-2.92%)
GE   6.69 (+1.67%)
TSLA   887.88 (+6.33%)
T   31.00 (+0.45%)
F   5.83 (+2.10%)
GILD   75.66 (-2.79%)
DIS   119.14 (+1.57%)
NFLX   424.62 (+1.17%)
BA   151.28 (+3.72%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Harpoon TherapeuticsCellular Biomedicine GroupAutolus TherapeuticsNantkwestPrecision BioSciences
SymbolNASDAQ:HARPNASDAQ:CBMGNASDAQ:AUTLNASDAQ:NKNASDAQ:DTIL
Price Information
Current Price$18.19$13.25$12.32$7.55$7.37
52 Week RangeBuyHoldBuyN/ABuy
Beat the Market™ Rank
Overall Score1.31.11.40.71.6
Analysis Score3.53.23.50.03.4
Community Score2.22.32.42.63.0
Dividend Score0.00.00.00.00.0
Ownership Score1.00.01.01.01.0
Earnings & Valuation Score0.00.00.00.00.6
Analyst Ratings
Consensus RecommendationBuyHoldBuyN/ABuy
Consensus Price Target$31.17$21.67$22.67N/A$20.67
% Upside from Price Target71.39% upside63.58% upside83.98% upsideN/A180.42% upside
Trade Information
Market Cap$543.96 million$267.02 million$502.63 million$663.95 million$363.55 million
Beta1.31.582.093.051.7
Average Volume262,41584,679134,1472,252,004558,166
Sales & Book Value
Annual Revenue$5.78 million$340,000.00$2.91 million$40,000.00$22.24 million
Price / Sales78.65755.35169.9818,593.7617.19
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$3.82 per share$2.89 per share$6.35 per share$1.23 per share$2.72 per share
Price / Book4.764.581.946.142.71
Profitability
Net Income$-55,570,000.00$-49,980,000.00$-123,850,000.00$-65,790,000.00$-92,880,000.00
EPS($2.55)($2.63)($2.88)($0.70)($1.91)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-681.41%N/A-9,870.67%-112,350.85%-369.86%
Return on Equity (ROE)-53.62%-83.10%-45.59%-51.94%-60.32%
Return on Assets (ROA)-34.20%-51.14%-38.88%-43.75%-35.83%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.16%N/A0.08%0.10%N/A
Current Ratio5.40%1.00%10.78%3.10%7.02%
Quick Ratio5.40%1.00%10.78%3.10%7.02%
Ownership Information
Institutional Ownership Percentage77.13%21.96%38.12%6.19%49.35%
Insider Ownership Percentage34.90%9.10%N/A72.08%14.30%
Miscellaneous
Employees45193N/A161127
Shares Outstanding25.00 million19.39 million40.15 million98.51 million51.86 million
Next Earnings Date8/3/2020 (Estimated)8/4/2020 (Estimated)N/A8/4/2020 (Estimated)8/12/2020 (Estimated)
OptionableNot OptionableOptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.